Abstract:Diabetes is strongly associated with erectile dysfunction, which is itself a risk factor for cardiovascular events and mortality. Evidence shows that phosphodiesterase type 5 inhibitor (PDE5I) use in men with type 2 diabetes mellitus is associated with a significant reduction in all‐cause mortality and morbidity. Despite the evidence, PDE5Is appear to be underused in this male cohort.
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.